Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Seizures: Classification01:13

Seizures: Classification

300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

321
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
321
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

240
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
240
Genetic Lingo01:11

Genetic Lingo

100.8K
Overview
100.8K
Incomplete Dominance01:43

Incomplete Dominance

21.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
21.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical and EEG features integrated by a deep learning method to investigate treatment outcomes in epilepsy with eyelid myoclonia.

Seizure·2026
Same author

Health-Related Quality of Life and Family Impact Among Children with Epilepsy: The Role of Seizure Control.

Neuroepidemiology·2026
Same author

PARS2 deficiency impairs mitochondrial homeostasis and activates ferroptotic to drive developmental and epileptic encephalopathy.

Free radical biology & medicine·2026
Same author

Phenotype and genotype of AKT3-related disorders.

Seizure·2026
Same author

KCNA2 Variants in Epilepsy: Focusing on Spike-and-Wave Activation in Sleep.

Pediatric neurology·2026
Same author

Cross-sectional study on the relationship between sarcopenia indicators and lung function in a community-dwelling population.

Frontiers in nutrition·2026

相关实验视频

Updated: Jun 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

与缺席发作相关的SETD1B变异.

Genfu Zhang1, Yue Niu1, Zhao Xu1

  • 1Department of Pediatrics, Peking University People's Hospital, Beijing, China; Epilepsy Center, Peking University People's Hospital, Beijing, China.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
|January 7, 2025
PubMed
概括

在SETD1B的遗传变异与儿科患者的缺席发作 (ASs) 有关. 这些SETD1B变化可能会影响神经元功能,并有助于AS的发展,影响大脑发育和认知功能.

关键词:
缺席性发作 缺席性发作是一种病.基因基因 基因基因 基因基因这就是SETD1B.

更多相关视频

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.5K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.8K

相关实验视频

Last Updated: Jun 3, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.5K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.8K

科学领域:

  • 遗传学 遗传学 是一个
  • 神经科学是一个神经科学.
  • 的研究研究.

背景情况:

  • 缺席发作 (AS) 是一种具有复杂遗传基础的类型.
  • SETD1B基因变异已与神经发育障碍有关,但它们在AS中的特定作用仍在调查中.

研究的目的:

  • 探索SETD1B基因变异与缺席发作 (ASs) 的发生之间的关联.
  • 研究具有SETD1B变体和ASs的个体的临床表型和遗传格局.

主要方法:

  • 研究了一组由四名患有SETD1B变异的儿科患者组成的队列.
  • 在基因查中使用了基于trio的全外组测序.
  • 研究人员对50个与SETD1B变化相关的AS病例进行了文献审查.

主要成果:

  • 四个新的病例呈现出发育障碍,认知缺陷和症状.
  • 在54个人中,48.1%患有AS,中位数发病年龄为44.8个月.
  • 在46.2%的AS患者中,在SET域中发现了SETD1B变异,通常具有认知和自闭症特征.

结论:

  • SETD1B变体可能对ASs的发病有影响,可能是通过通过组织蛋白甲基化影响神经元刺激性.
  • 这项研究强调了ASs在SETD1B表型中的重要性,并表明SET域在AS病变发生过程中的作用.